Researchers at The GW Medical Faculty Associate’s ALS Clinic are conducting clinical research trials to learn more about amyotrophic lateral sclerosis, or as more commonly known, Lou Gehrig’s Disease.
Clinical research trials search for new ways to prevent, understand and/or treat disease. The goal of these trials is to see if a new treatment, procedure or device works and is safe to use. Participating in a research trial, as either a healthy volunteer or a patient volunteer, is an opportunity to help researchers find better treatments for others in the future.
The following are clinical research trials specific to ALS:
Title: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) (COURAGE-ALS)
Principal Investigator: Elham Bayat, M.D.
Status of Research Trial: Open to enrollment
Sponsor of Research Trial: Cytokinetics
Description of Research Trial: Amyotrophic lateral sclerosis, or ALS, is a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. In ALS, progressive death of motor neurons leads to denervation of skeletal muscles. This clinical research trial compares the effectiveness of the drug reldesemtiv with that of a placebo in ALS progression.
Research Trial Contact Information: For more information, interested participants and clinicians may contact the Neurology Clinical Research Unit at email@example.com.